Background illustration for clinical trials search

Paid Clinical Trials Oklahoma City

Discover 572 paid clinical trials in Oklahoma City, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

for
Advanced Cancer, Metastatic Cancer, Ovarian Cancer,
Location: Oklahoma City OK, Dallas TX, St Louis MO, Denver CO,
Sponsor: Artios Pharma Ltd

Sex: All

Age: 18+

Code: NCT04657068

Phase 1, Phase 2, Recruiting

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Oklahoma City OK, Houston TX
Sponsor: Imunon

Sex: Female

Age: 18+

Code: NCT05739981

Phase 1, Phase 2, Recruiting

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

for
Solid Tumors With HRAS Alterations,
Location: Oklahoma City OK, Dallas TX, Houston TX, St Louis MO,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06026410

Phase 1, Recruiting

Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer

for
Head and Neck Cancer, Gynecologic Cancer, Cervical Cancer,
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18+

Code: NCT05850663

Recruiting

REVEAL Biomarkers of Engraftment After Alternative Donor HSCT

for
Primary Graft Failure
Location: Oklahoma City OK, Atlanta GA, Ann Arbor MI
Sponsor: University of Oklahoma

Sex: All

Age: 4 - 70+

Code: NCT03541889

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

for
Colorectal Cancer, CRC, Pancreatic Ductal Adenocarcinoma, PDAC,
Location: Oklahoma City OK, Irving TX, Westwood KS, Omaha NE,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06445062

Phase 1, Phase 2, Recruiting

Study of SGR-3515 In Participants With Advanced Solid Tumors.

for
Advanced Solid Tumor
Location: Oklahoma City OK, Dallas TX, Nashville TN, Chicago IL,
Sponsor: Schrödinger, Inc.

Sex: All

Age: 18+

Code: NCT06463340

Phase 1, Recruiting

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

for
Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer,
Location: Oklahoma City OK, Houston TX, Birmingham AL,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT03564340

Phase 1, Phase 2, Recruiting

Study of XB010 in Subjects With Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors,
Location: Oklahoma City OK, Dallas TX, Austin TX, Houston TX,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06545331

Phase 1, Recruiting

Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)

for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Oklahoma City OK, Omaha NE, St Louis MO, Santa Fe NM,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06295731

Phase 2, Phase 3, Recruiting

A Study of Sovilnesib in Subjects With Ovarian Cancer

for
High Grade Serous Adenocarcinoma of Ovary,
Location: Oklahoma City OK, Birmingham AL, Atlanta GA, Buffalo NY
Sponsor: Volastra Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06084416

Phase 1, Recruiting

Biopsy-site-marker in Breast Cancer

for
Breast Cancer
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: Female

Age: 18+

Code: NCT07833566

Recruiting

The Role of Dietary Fiber in Mitigating Sarcopenia Risk in Head and Neck Cancer

for
Head and Neck Cancers
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18+

Code: NCT07622914

Recruiting

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

for
Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer,
Location: Oklahoma City OK, Austin TX, Aurora CO, Nashville TN,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT07024784

Phase 2, Recruiting

A Clinical Study of YL205 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Oklahoma City OK, St Louis MO, Albuquerque NM,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06459973

Phase 1, Phase 2, Recruiting

Program in Oncology for Tribal Health Systems.

for
Patient Outcomes
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18+

Code: NCT07217574

Recruiting

Circulating Tumor DNA Response In Urothelial Cancer

for
Urothelial Carcinoma
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18+

Code: NCT07183319

Phase 2, Recruiting

Protoacoustic Imaging For 3D Mapping

for
Proton Therapy, Radiation Therapy, Secondary Skin Reactions,
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18+

Code: NCT07832617

Recruiting

Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

for
Breast Cancer, Prostate Cancer
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18+

Code: NCT07014618

Recruiting

Clinical Pre-screening Protocol for Ovarian Cancer

for
Ovarian Cancer
Location: Oklahoma City OK, Lubbock TX, Albuquerque NM,
Sponsor: Allarity Therapeutics

Sex: Female

Age: 18+

Code: NCT03877796

Recruiting